Access 2.8M+ Filings Sign Up Free
Formycon AG Logo

Formycon AG | FYB - Profile, Filings, Stock Info & Investor Relations Data

Formycon AG | FYB
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
Germany
Founded
1999
Formycon AG (FYB)

Company Profile

Website
Investor Relations

About Formycon AG

Formycon is a world-leading, independent developer of high-quality biosimilars, meaning follow-on products to biopharmaceutical medicines already on the market.

Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Our company’s activities span the entire range from technical- pharmaceutical development to clinical trials all the way through to preparation and submission of dossiers for regulatory approval.

We develop biosimilar medicines to meet the high standards of the world’s most stringently regulated markets: the European Union, the United States, Canada, Japan and Australia. We will continue to expand our position as a globally operating company in the growth market of biosimilars in line with our growth strategy.

Employees

171

Market Presence

Worldwide

Headquarters

Fraunhoferstraße 15
82152, Planegg
Germany

Company Video

Video thumbnail
Click to load video from YouTube

Formycon AG (FYB)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Formycon AG (FYB)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
Seidl, Dr. Andreas (Board)
Buy EUR 4,800.00 EUR 30.00 21.02.25
↑
Mikulcik, Dr. Marc (Close relation)
Buy EUR 48,000.00 EUR 40.00 29.04.24
↑
Glombitza, Dr. Stefan (Board)
Buy EUR 97,444.00 EUR 38.98 24.04.24

Formycon AG (FYB)
Stock & Investor Information

ISINs

DE000A1EWVY8

LEI

39120005TZ76GQOY8Z19

Stock Exchange Listings

Frankfurt Stock Exchange

Industry Classification

Sector
Health Care
Industry
Biotechnology